Analytica chimica acta · 2026
Simultaneous multi-biomarker detection: streptavidin-biotin mediated high-quality quantum dot immunosensor with signal amplification.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Xing Huanhuan, Zhang Ruixue, Li Ning, Li Xiaoquan, Lada Zoi G, Stamatatos Theocharis C, Chen Xinxin, Shen Huaibin, Xu Dangdang, Xing Xiaojing, Wu Ruili, Li Lin Song
Аннотация
BACKGROUND: Developing highly sensitive, high-throughput, and multiplexed detection methods for tumor markers is critical for early cancer diagnosis. Traditional streptavidin-biotin (SA-biotin) quantum dot (QD) immunoassays often struggle to detect multiple biomarkers simultaneously within a single reaction environment. This study aims to address these limitations by designing a highly sensitive, SA-biotin-mediated, dual-color QD fluorescence signal amplification immunosensor for the simultaneous detection of prostate-specific antigen (PSA) and alpha-fetoprotein (AFP) as model analytes within a single microplate well.
RESULTS: The immunosensor utilizes SA-modified red and green QD linked to biotin-PEG12-NHS ester-modified secondary antibodies (Ab2) to form dual-color QD-SA-bio-Ab2 probes. This architecture leverages the high-affinity SA-biotin interaction and the long spacer arm of biotin-PEG12-NHS to increase antibody loading and reduce steric hindrance, creating a synergistic signal amplification effect. Under optimized conditions, the sensor demonstrated a wide linear range for both PSA and AFP (0.5 to 1000 ng/mL). The limits of detection (LOD) were 0.25 ng/mL for PSA and 0.32 ng/mL for AFP-approximately 6-fold lower than standard dual-color QD-based immunosensors. The platform's accuracy was validated through recovery tests and clinical serum sample analysis, yielding results competitive with currently prevalent testing technologies.
SIGNIFICANCE: The proposed dual-color QD-SA-bio-Ab2 probe provides a universal fluorescent platform that overcomes the multiplexing constraints of traditional assays. By combining high-performance QD with a strategic PEG-spacer architecture, this method offers a novel approach for fluorescence enhancement. It represents a significant step forward in achieving high-sensitivity, high-throughput multiplexed detection in clinical diagnostics.
RESULTS: The immunosensor utilizes SA-modified red and green QD linked to biotin-PEG12-NHS ester-modified secondary antibodies (Ab2) to form dual-color QD-SA-bio-Ab2 probes. This architecture leverages the high-affinity SA-biotin interaction and the long spacer arm of biotin-PEG12-NHS to increase antibody loading and reduce steric hindrance, creating a synergistic signal amplification effect. Under optimized conditions, the sensor demonstrated a wide linear range for both PSA and AFP (0.5 to 1000 ng/mL). The limits of detection (LOD) were 0.25 ng/mL for PSA and 0.32 ng/mL for AFP-approximately 6-fold lower than standard dual-color QD-based immunosensors. The platform's accuracy was validated through recovery tests and clinical serum sample analysis, yielding results competitive with currently prevalent testing technologies.
SIGNIFICANCE: The proposed dual-color QD-SA-bio-Ab2 probe provides a universal fluorescent platform that overcomes the multiplexing constraints of traditional assays. By combining high-performance QD with a strategic PEG-spacer architecture, this method offers a novel approach for fluorescence enhancement. It represents a significant step forward in achieving high-sensitivity, high-throughput multiplexed detection in clinical diagnostics.